Osaic Holdings
HUMA icon

Osaic Holdings’s Humacyte HUMA Stock Holding History

Osaic Holdings’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$44.1K Buy
56,572
+1,734
+3% +$1.61K ﹤0.01% 5573
2026
Q1 		$33.4K Sell
54,838
-11,159
-17% -$11.6K ﹤0.01% 5508
2025
Q4 		$63.4K Sell
65,997
-7,893
-11% -$11.2K ﹤0.01% 5072
2025
Q3 		$122K Sell
73,890
-19,350
-21% -$37.9K ﹤0.01% 4624
2025
Q2 		$195K Sell
93,240
-1,760
-2% -$3.38K ﹤0.01% 3968
2025
Q1 		$162K Sell
95,000
-2,129
-2% -$7.99K ﹤0.01% 3800
2024
Q4 		$490K Buy
97,129
+19,817
+26% +$98.1K ﹤0.01% 2816
2024
Q3 		$421K Buy
77,312
+26,777
+53% +$177K ﹤0.01% 3042
2024
Q2 		$243K Buy
50,535
+3,455
+7% +$18K ﹤0.01% 3388
2024
Q1 		$146K Buy
47,080
+6,555
+16% +$22K ﹤0.01% 3938
2023
Q4 		$115K Buy
40,525
+925
+2% +$2.37K ﹤0.01% 4335
2023
Q3 		$116K Buy
39,600
+5,615
+17% +$18.6K ﹤0.01% 4396
2023
Q2 		$97.2K Buy
33,985
+4,775
+16% +$17.2K ﹤0.01% 4458
2023
Q1 		$90.4K Buy
29,210
+1,481
+5% +$4.21K ﹤0.01% 4530
2022
Q4 		$58K Buy
27,729
+825
+3% +$2.5K ﹤0.01% 4819
2022
Q3 		$88K Buy
26,904
+50
+0.2% +$192 ﹤0.01% 4480
2022
Q2 		$86K Buy
26,854
+1,834
+7% +$10.2K ﹤0.01% 4536
2022
Q1 		$177K Buy
25,020
+4,946
+25% +$28.8K ﹤0.01% 4138
2021
Q4 		$146K Buy
20,074
+1,850
+10% +$18.3K ﹤0.01% 4237
2021
Q3 		$211K Buy
18,224
+5,674
+45% +$64.9K ﹤0.01% 3847
2021
Q2 		$128K Buy
12,550
+11,550
+1,155% +$119K ﹤0.01% 4262
2021
Q1 		$11K Buy
+1,000
New +$10.9K ﹤0.01% 5821

Other funds holding HUMA

AP
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Osaic Holdings's HUMA Position: Q2 2026 in Review

Osaic Holdings increased its Humacyte (HUMA) stake by 3.2% in Q2 2026, buying an estimated $1.61K and bringing the position to 56,572 shares worth $44.1K. The position accounts for ﹤0.01% of the portfolio, ranked #5573.

Osaic Holdings first reported a position in HUMA in Q1 2021 and has held it in 22 quarters since. The position peaked at $490K in Q4 2024. 161 funds tracked by Wall St. Rank hold HUMA as of Q2 2026.

  • Osaic Holdings held 56,572 shares of Humacyte worth $44.1K as of Q2 2026.
  • Osaic Holdings bought 1,734 Humacyte shares in Q2 2026, an estimated $1.61K.
  • Humacyte made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #5573 holding.
  • Osaic Holdings first reported a position in Humacyte in Q1 2021 and has held it in 22 quarters since.
  • Osaic Holdings's Humacyte position peaked at $490K in Q4 2024.
  • 161 funds tracked by Wall St. Rank held Humacyte as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.